- Oct 27, 2017Mylan's EpiPen4Schools® Program Surpasses One Million Free Epinephrine Auto-Injector Donations to U.S. Schools- 2017 marks the five-year anniversary of Mylan's EpiPen4Schools® program.
- Oct 16, 2017
- Oct 5, 2017Mylan, in Partnership with Synthon, Receives Marketing Authorization Approval in Europe for First Generic for Copaxone® 40 mg/mLMylan Has Exclusive Rights for Glatiramer Acetate in Several Key European Markets
- Oct 4, 2017More than 6 Million Doses of Medicine Plus Financial and Other Assistance Provided to Affected Areas
- Oct 3, 2017Mylan Announces U.S. FDA Approval of First Generic for Copaxone® 40 mg/mL 3-Times-a-Week and May Be Eligible for 180-Day ExclusivityMylan Also Receives U.S. FDA Approval of Generic for Copaxone® 20 mg/mL Once-Daily
- Oct 2, 2017